Physician profile
Brianne N Plante
NPI 1225340938
$1,018.42
in general payments reported to CMS, 2019-2025
21 companies · $507 in 2025
The $507 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.86 · 2020: $11.63 · 2021: $12.69 · 2023: $114 · 2024: $323 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $198.49 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $144.66 | 2025 | Veozah |
| Biogen, INC. | $78.76 | 2025 | Zurzuvae |
| Abbvie INC. | $74.19 | 2024-2025 | |
| Allergan, INC. | $61.49 | 2019-2020 | |
| Gynesonics, INC. | $54.29 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $53.54 | 2023-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $46.17 | 2025 | |
| Daiichi Sankyo INC. | $36.91 | 2024-2025 | Injectafer |
| Boston Scientific Corporation | $36.12 | 2024-2025 | Lynx System |
| Baxter Healthcare | $33.83 | 2025 | Tisseel |
| Alexion Pharmaceuticals, INC. | $31.66 | 2024-2025 | Ultomiris |
| Aspira Women'S Health INC | $29.53 | 2024 | Ova1 |
| Minerva Surgical, INC | $29.41 | 2021-2023 | |
| Abbott Laboratories | $22.86 | 2023 | Proclaim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.33 | 2024 | |
| Novo Nordisk INC | $18.37 | 2025 | Wegovy |
| Hologic Sales and Service, LLC | $17.60 | 2023 | Coolseal Generator |
| Shield Therapeutics INC | $16.67 | 2025 | |
| Optumhealth Care Solutions, LLC | $13.54 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianne Plante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.